Description
Established from the explant of a 7 day old tumour from the parental Ehrlich-Lettre Ascites carcinoma. Prior to development, strain E was subjected to a schedule of seven mouse passages and six in vitro passages over a period of 17 months. The cells exhibit an unusually high mean chromosome number and possess the marker chromosomes present in the parental Ehrlich tumour. This cell line may be of use in comparative testing of anti-tumour agents in vivo and in vitro.
Adherent Suspension
Adherent
Suggested Medium
NCTC 135 + 2mM Glutamine + 10% Foetal Bovine Serum (FBS).
Quality Control
Ehrlich-Lettre Ascites strain E Cell Line was tested and found to be free of mycoplasma, bacterial, viruses, and other toxins. All cells were above 95% viability before freezing.
Shippment
Ehrlich-Lettre Ascites strain E Cell Line will be shipped using dry ice.
Storage
Store the cell lines in liquid nitrogen vapor (less than -130°C)
Warranty
Ehrlich-Lettre Ascites strain E Cell Line is for research use only
